A mathematical model of human T-cell lymphotropic virus type 1 in vivo with cell-to-cell infection and mitosis is formulated and studied. The basic reproductive number 0 is derived. It is proved that the dynamics of the model can be determined completely by the magnitude of 0 . The infection-free equilibrium is globally asymptotically stable (unstable) if 0 < 1 ( 0 > 1). There exists a chronic infection equilibrium and it is globally asymptotically stable if 0 > 1.
Introduction
Human T-cell lymphotropic virus type 1 (HTLV-1) is a pathogenic retrovirus and persists indefinitely in the infected hosts [1] [2] [3] [4] . There are approximately 10-20 million infected people worldwide [5, 6] . HTLV-1 is associated causatively with a large number of pathologies. A slowly progressive neurologic disease HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) [7] and adult T-cell leukemia (ATL) are two most common forms of the disease [8] . The majority of HTLV-1 infected individuals remain lifelong asymptomatic carriers (ACs). The remaining 0.25-3% of infected individuals develop into HAM/TSP [9] . The virus can be transmitted from mother to child, through sexual contact, and by needle sharing and contaminated blood products [5, 9] .
In HTLV-1 infection, the initial infection is subclinical. The virus preferentially integrates into the genome of host T lymphocytes. Since the virions are almost undetectable from extracellular matrix, the viral burden is quantified as the proportion of peripheral blood mononuclear cells that carry an integrated HTLV-1 provirus. About 90-95% of the proviral load in chronic HTLV-1 infection is carried by 4 + T cells and 5-10% by 8 + T cells [10] [11] [12] [13] .
To persist within the host, HTLV-1 requires two routes: (i) infectious spread to uninfected cells via cell-to-cell contact known as the virological synapse, cellular conduits, extracellular viral assemblies, and transinfection via dendritic cells [9] and (ii) clonal expansion, which would actively promote mitotic proliferation of infected cells, and pass on the provirus to daughter cells. It is assumed that infection of an individual with HTLV-1 occurs in two stages; the virus is thought to initially spread from T cells to T cells, primarily 4 + T cells, and later to persist by clonal expansion of infected cells [12] .
It has been observed that HTLV-1 infection has a lower rate of proviral genetic variation than HIV infection, which suggests that the vertical transmission through mitotic division rather than horizontal transmission through cell-to-cell contact plays an important role [14, 15] . HTLV-1 succeeds in causing a persistent infection with a high proviral load and remains approximately stable in one individual over years. In order to identify the underlying mechanism of HTLV-1 persistence in vivo and the key factors determining the HTLV-1 provirus load and the disease risk, Asquith and Bangham [1] have used a combination of mathematical and experimental techniques to propose a model of HTLV-1 persistence. Mitosis is the main route of viral replication, and the expression of HTLV-1 proteins, particularly Tax, is required to promote the 2 Abstract and Applied Analysis selective expansion of cells that harbour a provirus [5, [16] [17] [18] , though the majority of infected cells are not expressing viral protein. Although the Tax expressing is silenced in the majority of surviving cells and a small proportion (0.03%-3%) of infected cells can express Tax, the cells with Tax expression proliferate more rapidly than silently infected and uninfected cells, leading to the selective expansion of infected cells and an increase in proviral load [1] . The small proportion of infected cells that express viral proteins play a crucial role, and the very high provirus load in HTLV-1 infection is maintained by proliferation of infected T cells, induced by the Tax protein of HTLV-1 [19] .
It has been observed that the 4 + T cells population from HAM/TSP patients express higher levels of tax mRNA than 4 + T cells from ACs. Tax expression at any given proviral load is significantly higher in the HAM/TSP patients than that in the ACs [20] ; thus a high rate of viral protein expression is associated with a large increase in the prevalence of HAM/TSP, and Tax expression is a significant predictor of the disease [1] .
Most of the existing models have considered the persistence and pathogenesis for HTLV-1 infection of 4 + T cells. Mathematical models that take into account both infectious and mitotic routes have also been developed to describe the interaction in vivo among HTLV-1 [14, [20] [21] [22] . Motivated by the new hypothesis of HTLV-1 infection by Asquith and Bangham, we construct a model with three compartments, healthy 4 + T cells , resting infected 4 + T cells , and Tax-expressing infected 4 + T cells , to investigate the dynamics of the HTLV-1 infection. The model is formulated and the required conditions are given in Section 2. The stability of equilibria is presented in Section 3. The simulations are done in Section 4. The concluding remarks are given in Section 5.
Model Formulation
In this section, we construct a mathematical model including the spontaneous HTLV-1 antigen Tax expression, cell-to-cell contact, and mitotic infectious routes to describe the viral dynamics. Let ( ) be the number of healthy 4 + T cells at time , let ( ) be the number of the resting infected 4 + T cells at time , and let ( ) be the number of Taxexpressing infected 4 + T cells at time . We consider only HAM/TSP among nonmalignant HTLV-1 infection diseases; the dynamics of ATL and other aggressive malignancies may be very different. Although mitosis occurs in all 4 + T cells as a natural process, normal homeostatic proliferation occurs at a very slower rate than that of selective mitotic division in Tax-expressing infected cells. We ignore the effects of passive homeostatic proliferation of the healthy and resting infected 4 + T cells to simplify the model. Healthy 4 + T cells are produced in bone marrow at a constant rate [23, 24] ; we assume that the new cells generated in the bone marrow are uninfected. The infected 4 + T cells can make the healthy 4 + T cells get infected through cell-to-cell contact. The infectious incidence is described by a bilinear term , where is the transmission coefficient among 4 + T cells [25] . The newly infected cells experience an irreparable destruction by the strong adaptive immune responses. As a result, a small fraction , ∈ (0, 1), survives after the immune attack and becomes the resting infected cells [14, 22] . Every day, a small proportion of resting infected cells express Tax with ∈ (0.3%, 3%) [26] . The mitotic transmission of HTLV-1 involving selective clonal expansion of these Tax-expressing 4 + T cells occurs at a rate . The newly infected cells from mitosis to the resting infected cells compartment are , ∈ (0, 1), with (1− ) staying in the Tax-expressing infected 4 + T-cell compartment. The transfers among those three compartments are shown in Figure 1 .
From the mechanism of the HTLV-1 infection and the schematic diagram we can have the following model consisting of three differential equations;
In model (1), 1 , 2 , and 3 are the removal rate of healthy 4 + T cells, resting infected 4 + T cells, and Taxexpressing infected 4 + T cells, respectively. From epidemiological background, it is natural to assume that the initial values of these variables and parameters are nonnegative.
We define the basic reproductive number of model (1) by the next generation matrix approach given in [27] . Let
The calculation shows that the spectral radius (the basic reproductive number) of −1 is
The basic reproductive number, 0 , gives the average number of the secondary infections caused by a single Tax-expressing infected 4 + T cell during its whole infectious period. 
Throughout the paper, we use the assumption
The inequality (A1) is equivalent to that /( + 2 ) 3 + (1 − ) / 3 < 1, which requires that the average number of the secondary infections by a single Tax-expressing infected 4 + T cell through mitosis should not be larger than one. If the inequality in (A1) does not hold, then the number of the infected cells may increase to infinity. The biological interpretation of (A1) is to keep the solutions of the model bounded. From condition (A1), we have < 3 /(1 − ); that is, 3 > (1 − ) . We can get the following nonnegative and bounded conclusions on the solutions of model (1).
Theorem 1. The solutions ( ( ), ( ), ( )) of model (1) with the nonnegative initial conditions are nonnegative and bounded for all
Proof. It is easy to have
From Lemma 2 in [28] , we know that any solutions of model (1) with nonnegative initial conditions will be nonnegative for all > 0. It follows from the first equation of model (1) that
which leads to lim → +∞ sup ≤ / 1 . Let = + + (( + 2 )/ ) ; from model (1) we can obtain
The inequality in (6) implies that = + +(( + 2 )/ ) will decrease along the solutions curve of model (1) 
and let 0 be the maximal value of the function + on the bounded domain
When + (( + 2 )/ ) ≤ 0 holds, the second equation of model (1) yields
From the comparison principle and (9), it follows that there exists a positive = 0 /( + 2 ), such that / ≤ 0 when > and + (( + 2 )/ ) ≤ 0 . For any given initial values (0) = 0 ≥ 0, (0) = 0 ≥ 0, and (0) = 0 ≥ 0, there exists a plane , given by the equation
such that the point ( 0 , 0 , 0 ) locates inside the domain with the boundaries = 0, = 0, = 0, = + 0 + 0 + (( + 2 )/ ) 0 , and . It is not difficult to verify that those two planes = + 0 + 0 + (( + 2 )/ ) 0 and have the intersection line + (( + 2 )/ ) = 0 . The equations in (6) and (9) imply that
Those inequalities imply that the domain with the boundaries = 0, = 0, = 0, = + 0 + 0 + (( + 2 )/ ) 0 , and is positively invariant for solutions of model (1) . That is, any solution of model (1) with nonnegative initial value is bounded.
With a similar argument as used in the proof of Theorem 1, we know that the domain
is positively invariant with respect to model (1). In fact, the solutions of model (1) located on the boundary planes of Γ, = / 1 , or = , or + + (( + 2 )/ ) = 0 + , will enter Γ 0 , where Γ 0 is the interior of Γ. From (5), (6) , and (9) we can prove that all the solutions of model (1) with positive initial values will enter Γ when the time is large enough. We will investigate the dynamic behavior of model (1) on Γ in the rest of the paper.
The straightforward calculation shows that model (1) has two equilibria: the infection-free equilibrium 0 = ( 0 , 0, 0), located on the boundary of Γ, where 0 = / 1 , and the chronic infection equilibrium 1 = ( 1 , 1 , 1 ), where 
Stability Analysis of Equilibria

Stability of Infection-Free Equilibrium.
Intuitively, if 0 < 1, then a Tax-expressing infected 4 + T cell will produce less than one secondary infection on average in its lifetime. This fact may lead to the extinction of the infection. We will try to prove the global stability of the infection-free equilibrium when 0 < 1. Proof. We use the linearized system of model (1) to discuss the stability of 0 . The characteristic equation of the matrix of the linearized system of model (1) at the infection-free equilibrium 0 is
where
From the Routh-Hurwitz criterion, it is easy to know that all the roots of (14) have negative real parts if 0 < 1, and (14) has at least one root with positive real part if 0 > 1. This completes the proof. Proof. We consider a Lyapunov function = + ( + 2 ) . Calculating the derivative of along the solutions of model (1) gives (1) with initial values in Γ. The global stability conclusion of Theorem 4 is proved. Proof. The characteristic equation of the matrix of the linearized system of model (1) at the chronic infection equilibrium 1 is
Stability of the Chronic Infection Equilibrium
. The straightforward calculation yields 1 1 − 1 > 0. According to the Routh-Hurwitz criterion, we can see that all the roots of (16) have negative real parts if 0 > 1. This completes the proof of Theorem 5.
The following two lemmas, which can be found in [29] , are used for the study of the uniform persistence of model (1) . We show that the disease persists when 0 > 1; that is, the infected proportion of the 4 + T cells persists above a certain positive level for sufficiently large .
Let : → be a continuous map and 0 ⊂ an open set. Define 0 = / 0 and := { ∈ 0 | ( ) ∈ 0 , ≥ 0}.
Lemma 6 (see [29] (1) we have
It follows that
From the third equation of model (1) we have
then, for ∈ [0, 1], we can have
The inequalities ( ) ≥ 1 > 0 and From Proposition 8, we can get the conclusion that is the maximal invariant set in 0 . Next we show that the solutions with the initial values in 0 cannot go to the boundary. Proof. If the conclusion in Proposition 9 does not hold, then, for any > 0, there exists a such that ( ) ≤ and ( ) ≤ for all > . Consider the following equation:
The solution of (22) with the any initial value ( 0 ) > 0 iŝ
and lim → +∞̂( ) = /( + 1 ). For 1 > 0, there exists a
is an equilibrium of (22) . The fact that lim → 0̂1 ( ) = / 1 = 0 implies that̂1( ) ≥ 0 − 1 when is small enough. By the comparison principle, we can have ( ) ≥̂( ) and ( ) ≥ 0 − 2 1 , for > 1 . Consider the following linear system:
The characteristic equation is
. From the expression of 2 we see that 2 < 0 if 0 > 1 and 1 is small enough. Let 1 and 2 be the two roots of 2 + 2 + 2 = 0 and 1 > 0 > 2 . The solution of model (24) with the initial value (̂(0),̂(0)) > 0 satisfies
where 1 and 2 are the eigenvectors corresponding to 1 and 2 , respectively. 1 and 2 are two constants depending on (̂(0),̂(0)). The solution expression of model (24) 
Proof. and 0 are positively invariant for model (1) . Φ is point dissipative and compact. By Lemma 6 we know that there is a connected global attractor for Φ that attracts each bounded set in .
From the discussion of Proposition 8, we know that is the maximal compact invariant set in 0 . Since we choose the Morse decomposition of as { 0 } and ∪ ∈ ( ) = { 0 }, the set { 0 } is isolated. Proposition 9 shows that the solutions of model (1) with initial values in 0 cannot go to the boundary, which implies that ( 0 ) ∩ 0 = . It follows from Lemma 7 that model (1) is uniformly persistent with respect to ( 0 , 0 ).
The following lemmas in [30] [31] [32] are used to study the global stability of the chronic infection equilibrium 1 . We will show that all the solutions of model (1) 
Let ( , 0 ) be the solution of model (27) 
A set is said to be absorbing in for model (27) if ( , 1 ) ⊂ for each compact 1 ⊂ and sufficiently large . We make the following two basic assumptions.
( 1 ) There exists a compact absorbing set ⊂ .
( 2 ) System (27) has a unique equilibrium in .
System (27) is said to have the Poincaré-Bendixson Property if any nonempty compact omega limit set that contains no equilibrium is a closed orbit [31] . It is known that a three-dimensional competitive system has the Poincaré-Bendixson property in a convex region.
Lemma 11 (see [30] ). Let ∈ be convex. The autonomous system / = ( ), ∈ , is cooperative in if there exists a diagonal matrix = diag( 1 , . . . , ) ( = −1 or 1, = 1, 2, . . . , ), such that ( / )( ) ≥ 0, for ̸ = , ∈ ; that is, all off-diagonal entries of ( / )( ) are nonnegative. It is competitive in if there exists a diagonal matrix = diag( 1 , . . . , ) ( = −1 or 1, = 1, 2, . . . , ), such that ( / )( ) ≤ 0, for ̸ = , ∈ ; that is, all off-diagonal entries of ( / )( ) are nonpositive.
Lemma 12 (see [32] ). Assume that = 3 and is convex; suppose that model (27) is competitive in ; then it satisfies the Poincaré-Bendixson property [32] .
Lemma 13 (see [31] ). Assume that the following conditions hold.
(1) Assumptions ( 1 ) and ( 2 ) hold; 
Then the unique equilibrium is globally asymptotically stable in .
Next, we show that model (1) is a competitive system which implies that model (1) has the Poincaré-Bendixson property.
Theorem 14. Model (1) is competitive in Γ.
Proof. The Jacobian matrix of model (1) is
Choose = diag(1, −1, 1); we can obtain
All off-diagonal entries of are nonpositive. It follows from Lemma 11 that model (1) is competitive in the convex region Γ. The second compound system of the linearized system along a periodic solution ( ( ), ( ), ( )) of model (1) is
In order to verify that model (30) is asymptotically stable, we define a Lyapunov function
From the uniform persistence, we know that the orbit O of the periodic solution ( ( ), ( ), ( )) has a positive distance from the boundary of Γ. There exists a constant > 0 such that
For all ( , , ) ∈ 3 and ( , , ) ∈ O, we have the following estimates on the right derivatives along the solutions ( ( ), ( ), ( )) of model (30):
From ( 
The inequalities in (33) and (34) lead to
After rewriting the last two equations of model (1), we find that
From (36) and (37), we obtain The inequalities in (35) and (38) imply that ( ) → 0 as → ∞, which leads to ( ( ), ( ), ( )) → 0 as → ∞ because of (32) . As a result, the second compound system (30) is asymptotically stable. This verifies condition (6) of Lemma 13.
Let ( 1 ) be the Jacobian matrix of model (1) at 1 . Then we have
Condition (9) of Lemma 13 holds. The chronic infection equilibrium 1 of model (1) is globally asymptotically stable in Γ 0 since all conditions of Lemma 13 are satisfied.
Numerical Simulation
Numerical simulations are done to demonstrate the results in Section 3. The sensitive analysis is given to show the effects of the model parameters on the solutions. In numerical simulations, the time scale is a day. [33] . In Figure 2 , we use the following set of parameters: = 20, = 0.001, 1 = 2 = 1/30, = 0.05, = 0.01, = 0.9, = 0.03, 3 = 0.05, and 0 = 0.5832 < 1. All solutions converge to the infection-free equilibrium 0 .
In Figure 3 A sensitivity analysis quantifies how changes in the values of the input parameters alter the value of the outcome variable [34] . The sensitivity analysis is performed to explore the behavior of model (1) by calculating the partial rank correlation coefficients (PRCC) for each input parameter, which are sampled by the Latin hypercube sample (LHS) and 0 (Table 1 ). Figure 4 shows that a significantly strong positive correlation exists between parameters and 0 (PRCC = 0.8597; value = 0 < 0.01). The second sensitive parameter to 0 is (PRCC = 0.3421; value = 0 < 0.01). The result indicates that the cell-to-cell contact transmission and Tax expression contribute a lot to the viral infection.
The sensitivity analysis result shows that and are two significant parameters for the infection. We illustrate the impact of and on the magnitude of the chronic infection equilibrium 1 by numerical simulations. The curves in 5(c) and 5(d) give the values of 1 or 1 as the functions of and , respectively. Those curves and surfaces in Figure 5 indicate that 1 and 1 will increase with and . For any given , 1 or 1 increases very fast for small and quite slow for large .
Concluding Remarks
We have formulated and studied a mathematical model of HTLV-1 in vivo including the spontaneous HTLV-1 antigen Tax expression, cell-to-cell contact, and mitotic infectious route to the viral dynamics. The persistence of the model is discussed. Sufficient conditions are established for the global asymptotic stability of the infection-free equilibrium and chronic infection equilibrium. The sensitivity analysis by PRCC with the LHS sample is presented to show the impact of the parameters on the model dynamics.
As we know, infected cells from HAM/TSP patients have a significantly higher probability of expressing Tax protein than infected cells from ACs. When an infected individual has settled at a chronic infection state, the proportion of Tax-expressing cells in infected cells is /( + ), where = (( 3 − (1 − ) )/ ) . Hence ( / )( /( + )) = ( 3 − (1 − ) )/( 3 − (1 − ) + ) 2 > 0. That is, a faster rate of spontaneous expression of the Tax results in a higher proportion of in infected 4 + T cells which influence the risk of HAM/TSP.
It follows from our sensitivity analysis that and are significantly sensitive to the reproduction number 0 . In particular, increasing the rate of Tax expression results in a reduction of the proportion of proviral cell at the equilibrium state. This conclusion implies that Tax expression should be controlled in the therapeutic intervention in order to reduce the risk of HAM/TSP.
Our conclusions are based on a simple model; with the recent progress in HTLV-1 pathogenesis and new findings in immune reactions against HTLV-1 infection and Tax expression, more factors should be investigated in improved models.
